Chang, C.-M.; Chang, C.-C.; Lam, H.Y.P.; Peng, S.-Y.; Lai, Y.-H.; Hsiang, B.-D.; Liao, Y.-Y.; Hsu, H.-J.; Jiang, S.-J.
Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis. Int. J. Mol. Sci. 2023, 24, 14029.
https://doi.org/10.3390/ijms241814029
AMA Style
Chang C-M, Chang C-C, Lam HYP, Peng S-Y, Lai Y-H, Hsiang B-D, Liao Y-Y, Hsu H-J, Jiang S-J.
Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis. International Journal of Molecular Sciences. 2023; 24(18):14029.
https://doi.org/10.3390/ijms241814029
Chicago/Turabian Style
Chang, Chun-Ming, Chun-Chun Chang, Ho Yin Pekkle Lam, Shih-Yi Peng, Yi-Hsuan Lai, Bi-Da Hsiang, Yu-Yi Liao, Hao-Jen Hsu, and Shinn-Jong Jiang.
2023. "Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis" International Journal of Molecular Sciences 24, no. 18: 14029.
https://doi.org/10.3390/ijms241814029
APA Style
Chang, C. -M., Chang, C. -C., Lam, H. Y. P., Peng, S. -Y., Lai, Y. -H., Hsiang, B. -D., Liao, Y. -Y., Hsu, H. -J., & Jiang, S. -J.
(2023). Therapeutic Peptide RF16 Derived from CXCL8 Inhibits MDA-MB-231 Cell Invasion and Metastasis. International Journal of Molecular Sciences, 24(18), 14029.
https://doi.org/10.3390/ijms241814029